CI
TAK icon

Cowen Inc’s Takeda Pharmaceutical TAK Stock Holding History

Cowen Inc’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$5.31M Buy
299,914
+5,000
+2% +$91K 0.38% 49
2019
Q1 		$6.01M Sell
294,914
-563,290
-66% -$11.3M 0.65% 29
2018
Q4 		$14.4M Buy
+858,204
New +$14.5M 1.6% 12

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cowen Inc's TAK Position: Q2 2019 in Review

Cowen Inc increased its Takeda Pharmaceutical (TAK) stake by 1.7% in Q2 2019, buying an estimated $91K and bringing the position to 299,914 shares worth $5.31M. The position accounts for 0.38% of the portfolio, ranked #49.

Cowen Inc first reported a position in TAK in Q4 2018 and has held it in 3 quarters since. The position peaked at $14.4M in Q4 2018. 347 funds tracked by Wall St. Rank hold TAK as of Q2 2019.

  • Cowen Inc held 299,914 shares of Takeda Pharmaceutical worth $5.31M as of Q2 2019.
  • Cowen Inc bought 5,000 Takeda Pharmaceutical shares in Q2 2019, an estimated $91K.
  • Takeda Pharmaceutical made up 0.38% of Cowen Inc's portfolio in Q2 2019, its #49 holding.
  • Cowen Inc first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 3 quarters since.
  • Cowen Inc's Takeda Pharmaceutical position peaked at $14.4M in Q4 2018.
  • 347 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.